Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | PGD | P52209 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18860460 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1USP2 | |
| SCHEMBL11348630 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1USP2 | |
| SCHEMBL1534011 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1USP2 | |
| Bromide SCHEMBL8581006 | 0.98 | TDP1 (0.69) | TDP1ABCB1POLBMAPK1USP2 | |
| SCHEMBL10598584 | 0.95 | TDP1 (0.68) | TDP1ABCB1POLBMAPK1USP2 | |
| SCHEMBL5167248 | 0.89 | TDP1 (0.64) | TDP1ABCB1POLBMAPK1USP2 | |
| SCHEMBL7149374 | 0.86 | TDP1 (0.96) | TDP1ABCB1POLBMAPK1MAPT | |
| SCHEMBL2175855 | 0.86 | TDP1 (0.96) | TDP1ABCB1POLBMAPK1MAPT | |
| SCHEMBL826717 | 0.86 | TDP1 (0.96) | TDP1ABCB1POLBMAPK1MAPT | |
| SCHEMBL270042 | 0.86 | TDP1 (0.96) | TDP1ABCB1POLBMAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101203249-A | Poly (peptide) as chelating agent: method of manufacture and use | UNIV TEXAS (US) | 2008-06-18 | — | — | CN | claimed |
| US-20240335551-A1 | FUNCTIONAL MOIETIES AND THEIR USES AND SYNTHETIC PREPARATION | OLIX US, INC. | 2024-10-10 | — | — | US | disclosed |
| EP-4341269-A1 | FUNCTIONAL MOIETIES AND THEIR USES AND SYNTHETIC PREPARATION | Olix US, Inc. (US) | 2024-03-27 | — | — | EP | disclosed |
| WO-2022246195-A1 | FUNCTIONAL MOIETIES AND THEIR USES AND SYNTHETIC PREPARATION | OLIX US, INC. (US) | 2022-11-24 | — | — | WO | disclosed |
| CN-101203249-A | Poly (peptide) as chelating agent: method of manufacture and use | UNIV TEXAS (US) | 2008-06-18 | — | — | CN | disclosed |
| US-7335500-B2 | Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-02-26 | — | — | US | disclosed |
| US-20020068331-A1 | Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose | WONG CHI-HUEY (US) | 2002-06-06 | — | — | US | disclosed |
| EP-0910568-A4 | SULFINYL HEXOSE DERIVATIVES USEFUL FOR GLYCOSYLATION | UNIV PRINCETON (US) | 2002-04-24 | — | — | EP | disclosed |
| US-6319695-B1 | FORMING A GLYCOSIDE BOND BY ETHERIFICATION AND CIRCULATION | THE SCRIPPS RESEARCH INSITUTE | 2001-11-20 | — | — | US | disclosed |
| US-6040433-A | Sulfinyl hexose derivatives useful for glycosylation | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2000-03-21 | — | — | US | disclosed |
| EP-0901629-A4 | CARBOHYDRATE-BASED LIGAND LIBRARY, ASSAY AND METHOD | UNIV PRINCETON (US) | 2000-02-02 | — | — | EP | disclosed |
| EP-0910568-A1 | SULFINYL HEXOSE DERIVATIVES USEFUL FOR GLYCOSYLATION | PRINCETON UNIVERSITY (US) | 1999-04-28 | — | — | EP | disclosed |
| EP-0901629-A1 | CARBOHYDRATE-BASED LIGAND LIBRARY, ASSAY AND METHOD | PRINCETON UNIVERSITY (US) | 1999-03-17 | — | — | EP | disclosed |
| EP-0642526-B1 | PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE | SCRIPPS RESEARCH INST (US) | 1998-12-23 | — | — | EP | disclosed |
| WO-1997035202-A1 | CARBOHYDRATE-BASED LIGAND LIBRARY, ASSAY AND METHOD | PRINCETON UNIVERSITY (US) | 1997-09-25 | — | — | WO | disclosed |
| WO-1997034906-A1 | SULFINYL HEXOSE DERIVATIVES USEFUL FOR GLYCOSYLATION | PRINCETON UNIVERSITY (US) | 1997-09-25 | — | — | WO | disclosed |
| EP-0642526-A4 | PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE. | SCRIPPS RESEARCH INST (US) | 1996-04-10 | — | — | EP | disclosed |
| EP-0642526-A1 | PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE | THE SCRIPPS RESEARCH INSTITUTE (US) | 1995-03-15 | — | — | EP | disclosed |
| WO-1993008205-A1 | PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE | THE SCRIPPS RESEARCH INSTITUTE (US) | 1993-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240335551-A1 | FUNCTIONAL MOIETIES AND THEIR USES AND SYNTHETIC PREPARATION | FGB, SELP, PTMS | TDP1 2764/4885ABCB1 3837/4885POLB 585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.